Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
filingDate |
2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102115060-B1 |
titleOfInvention |
Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same |
abstract |
The present invention is N - (3- (4- (3- ( di-isobutyl amino) propyl) piperazine-1-yl) propyl) -1 H - benzo [d] imidazol-2-amine sulfate and medicaments of significant It is acceptable for use as a solvent compound, its preparation, pharmaceutical compositions comprising it, and its use in the treatment and / or prevention of neurodegenerative diseases. |
priorityDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |